PDE6B

Chr 4ADAR

phosphodiesterase 6B

Also known as: CSNB3, CSNBAD2, GMP-PDEbeta, PDEB, RP40, rd1

PDE6B encodes the beta subunit of rod-specific cGMP phosphodiesterase, which catalyzes the hydrolysis of cGMP in the visual signal transduction cascade of rod photoreceptors. Mutations cause retinitis pigmentosa-40 and autosomal dominant congenital stationary night blindness, with inheritance patterns including both autosomal dominant and autosomal recessive forms. The gene shows tolerance to loss-of-function variants (LOEUF 1.187), indicating that different mutation types may lead to distinct clinical phenotypes.

Summary from RefSeq, OMIM, UniProt
Research Assistant →

Primary Disease Associations & Inheritance

Night blindness, congenital stationary, autosomal dominant 2MIM #163500
AD
Retinitis pigmentosa-40MIM #613801
AR
3
Active trials
24
Pubs (1 yr)
76
P/LP submissions
5%
P/LP missense
1.19
LOEUF
Multiple*
Mechanism· G2P
Clinical SummaryPDE6B
🧬
Gene-Disease Validity (ClinGen)
inherited retinal dystrophy · ARDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
74 unique Pathogenic / Likely Pathogenic· 244 VUS of 500 total submissions
💊
Clinical Trials
3 active or recruiting trials — potential therapeutic options may be available
📖
GeneReview available — PDE6B
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.19LOEUF
pLI 0.000
Z-score 0.51
OE 0.92 (0.721.19)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
-0.80Z-score
OE missense 1.10 (1.021.18)
572 obs / 520.8 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios
LoF OE0.92 (0.721.19)
00.351.4
Missense OE1.10 (1.021.18)
00.61.4
Synonymous OE1.12
01.21.6
LoF obs/exp: 43 / 46.7Missense obs/exp: 572 / 520.8Syn Z: -1.42
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
definitivePDE6B-related retinitis pigmentosaLOFAR
strongPDE6B-related night blindness, congenital stationaryGOFAD
DN
0.6161th %ile
GOF
0.74top 25%
LOF
0.3746th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

500 submitted variants in ClinVar

Classification Summary

Pathogenic52
Likely Pathogenic22
VUS244
Likely Benign166
Benign1
Conflicting3
52
Pathogenic
22
Likely Pathogenic
244
VUS
166
Likely Benign
1
Benign
3
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
18
1
33
0
52
Likely Pathogenic
13
3
6
0
22
VUS
4
209
22
9
244
Likely Benign
0
5
77
84
166
Benign
0
0
1
0
1
Conflicting
3
Total3521813993488

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

PDE6B · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Literature
Open Research Assistant →
Key Publications
Landmark & review papers · by relevance
PubMed
Top 5 results · since 2015Search PubMed ↗